Korro Bio · Cambridge, MA, US
· Posted 2026-06-09
· 7+ years
Company Summary: Korro is a biopharmaceutical company focused on developing a new class of genetic medicines for both rare and highly prevalent diseases using its proprietary RNA editing platform. Korro is generating a portfolio of differentiated programs that are designed to harness the body’s natural RNA editing proc
ScientistAnalyticalScienceskorromethodsmethodgeneticmedicines
Korro Bio · Cambridge, MA, US
· Posted 2026-06-08
· 10+ years
Company Summary: Korro is a biopharmaceutical company focused on developing a new class of genetic medicines for both rare and highly prevalent diseases using its proprietary RNA editing platform. Korro is generating a portfolio of differentiated programs that are designed to harness the body’s natural RNA editing proc
DirectorClinicalSupplyChainManagementglobalregulatorycompliance
Korro Bio · Cambridge, MA, US
· Posted 2026-05-19
· 10+ years
Company Summary: Korro is a biopharmaceutical company focused on developing a new class of genetic medicines for both rare and highly prevalent diseases using its proprietary RNA editing platform. Korro is generating a portfolio of differentiated programs that are designed to harness the body’s natural RNA editing proc
DirectorToxicologykorroregulatorygeneticmedicinesnonclinicalsafety